NCT02785744View on ClinicalTrials.gov

Genzyme Osteopenia/Osteoporosis Study

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Gaucher Disease
Interventions
OTHER

Gaucher disease DNA mutation analysis

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

NYU Langone Health

OTHER

NCT02785744 - Genzyme Osteopenia/Osteoporosis Study | Biotech Hunter | Biotech Hunter